Rhofade
Product Images NDC 71180-003

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Rhofade (NDC 71180-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aclaris Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rhofade 01)

FDA Label Image

Step 1 (Rhofade 02)

FDA Label Image

Step 1 (Rhofade 03)

FDA Label Image

Step 2 (Rhofade 04)

FDA Label Image

Step 4 (Rhofade 05)

FDA Label Image

Step 1 (Rhofade 06)

FDA Label Image

Step 1 (Rhofade 07)

FDA Label Image

Step 1 (Rhofade 08)

FDA Label Image

Step 2 (Rhofade 09)

FDA Label Image

Step 4 (Rhofade 10)

FDA Label Image

Principal Display Panel (30 g Tube Carton)

Rhofade cream is a topical medication containing the active ingredient oxymetazoline hydrochloride, used for facial redness caused by rosacea. It is applied once a day on the forehead, nose, cheeks, and chin, avoiding the eyes and lips. It is important to keep Rhofade out of reach of children, and not use it in oral, ophthalmic or intravaginal areas. Each gram of cream contains 10mg of oxymetazoline hydrochloride. To open the tube, push the cap in and turn counterclockwise. It should be stored at 20°C-25°C (68°F-77°F). Ackris Therapeutics manufactures Rhofade, and it is made in the USA. There are some US patents involved in its production.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.